These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6772564)

  • 1. Enhancement of resistance to infections by endotoxin-induced serum factor from Mycobacterium bovis BCG-infected mice.
    Parant MA; Parant FJ; Chedid LA
    Infect Immun; 1980 Jun; 28(3):654-9. PubMed ID: 6772564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial resistance enhancing activity of tumor necrosis serum factor induced by endotoxin in BCG-treated mice.
    Parant M
    Recent Results Cancer Res; 1980; 75():213-9. PubMed ID: 7232834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum containing tumor necrosis factor is cytotoxic for the human malaria parasite Plasmodium falciparum.
    Haidaris CG; Haynes JD; Meltzer MS; Allison AC
    Infect Immun; 1983 Oct; 42(1):385-93. PubMed ID: 6352501
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificity of acquired resistance produced by immunization with mycobacterial cells and mycobacterial fractions.
    Coppel S; Youmans GP
    J Bacteriol; 1969 Jan; 97(1):114-20. PubMed ID: 4974383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An endotoxin-induced serum factor that causes necrosis of tumors.
    Carswell EA; Old LJ; Kassel RL; Green S; Fiore N; Williamson B
    Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3666-70. PubMed ID: 1103152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endotoxin neutralization by an O-antigen specific monoclonal antibody: A potential novel therapeutic approach against Klebsiella pneumoniae ST258.
    Szijártó V; Guachalla LM; Hartl K; Varga C; Badarau A; Mirkina I; Visram ZC; Stulik L; Power CA; Nagy E; Nagy G
    Virulence; 2017 Oct; 8(7):1203-1215. PubMed ID: 28103139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endotoxin-induced interferon-gamma production in culture cells derived from BCG-infected C3H/HeJ mice.
    Matsumura H; Nakano M
    J Immunol; 1988 Jan; 140(2):494-500. PubMed ID: 3121747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of increased metabolic activity, resistance to infection, enhanced phagocytosis, and inhibition of bacterial growth by macrophages from Listeria- and BCG-infected mice.
    Ratzan KR; Musher DM; Keusch GT; Weinstein L
    Infect Immun; 1972 Apr; 5(4):499-504. PubMed ID: 4629124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of BCG infection on the susceptibility of mouse macrophages to endotoxin.
    Peavy DL; Baughn RE; Musher DM; Musher DM
    Infect Immun; 1979 Apr; 24(1):59-64. PubMed ID: 378847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure of endotoxin to increase nonspecific resistance to infection of lipopolysaccharide low-responder mice.
    Chedid L; Parant M; Damais C; Parant F; Juy D; Galelli A
    Infect Immun; 1976 Mar; 13(3):722-7. PubMed ID: 773822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial purification of a serum factor that causes necrosis of tumors.
    Green S; Dobrjansky A; Carswell EA; Kassel RL; Old LJ; Fiore N; Schwartz MK
    Proc Natl Acad Sci U S A; 1976 Feb; 73(2):381-5. PubMed ID: 54919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired resistance against Listeria monocytogenes in red mice and CF1 mice immunized with strains of BCG or Mycobacterium tuberculosis.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Dec; 84B(6):379-85. PubMed ID: 826109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of suramin on the in vivo antimicrobial resistance against Listeria monocytogenes and Mycobacterium bovis (BCG) in mice.
    Brandely M; Lagrange PH; Hurtrel B
    Clin Exp Immunol; 1986 Jan; 63(1):118-26. PubMed ID: 3514011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acquired resistance of BCG-vaccinated red mice to infection with Listeria monocytogenes.
    Jespersen A
    Acta Pathol Microbiol Scand B; 1976 Oct; 84B(5):265-72. PubMed ID: 823794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice. I. In vivo studies.
    Vogel SN; Moore RN; Sipe JD; Rosenstreich DL
    J Immunol; 1980 Apr; 124(4):2004-9. PubMed ID: 6154089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin.
    Beutler B; Milsark IW; Cerami AC
    Science; 1985 Aug; 229(4716):869-71. PubMed ID: 3895437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular immune response to Mycobacterium bovis (BCG) in genetically-susceptible and resistant congenic mouse strains.
    Bourassa D; Forget A; Pelletier M; Skamene E; Turcotte R
    Clin Exp Immunol; 1985 Oct; 62(1):31-8. PubMed ID: 3905097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Production of tumor necrosis factor in unprimed mice: mechanism of endotoxin-mediated tumor necrosis.
    Flick DA; Gifford GE
    Immunobiology; 1986 Jul; 171(4-5):320-8. PubMed ID: 3527951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Killed Listeria-induced suppressor T cells involved in suppression of delayed-type hypersensitivity and protection against Listeria infection.
    Yamamoto K; Kato K; Kimura T
    Immunology; 1985 Aug; 55(4):609-19. PubMed ID: 2410356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes.
    van Faassen H; Dudani R; Krishnan L; Sad S
    J Immunol; 2004 Mar; 172(6):3491-500. PubMed ID: 15004149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.